NYTech
Companies
Companypublic companybiotech

Protara Therapeutics, Inc.

Protara Therapeutics, Inc. is a publicly traded company headquartered in New York City [1]. The company is listed on the Nasdaq exchange under the ticker symbol TARA [2]. According to the Securities and Exchange Commission, Protara Therapeutics operates in the biological products industry, excluding diagnostic substances [3]. The company was previously known as ArTara Therapeutics, Inc. and before that as Proteon Therapeutics Inc. [5][6]. In its most recent annual report to the SEC, Protara Therapeutics reported revenue of $2.9 million for the year ending December 31, 2014, and total assets of $209.5 million [7].

NYC headquarters

  • SEC filings list the business address of Protara Therapeutics, Inc. as 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010.[1]

financials

  • Reported revenue of $2.9 million for the year ending 2014-12-31 and total assets of $209.5 million in its most recent annual report to the SEC.[7]

Something wrong or missing? Send a correction. Fixed within 24 hours.